Your browser doesn't support javascript.
loading
Signature program: a platform of basket trials.
Slosberg, Eric D; Kang, Barinder P; Peguero, Julio; Taylor, Matthew; Bauer, Todd M; Berry, Donald A; Braiteh, Fadi; Spira, Alexander; Meric-Bernstam, Funda; Stein, Steven; Piha-Paul, Sarina A; Salvado, August.
Affiliation
  • Slosberg ED; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Kang BP; Current affiliation: Daiichi Sankyo, Inc, Basking Ridge, NJ, USA.
  • Peguero J; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Taylor M; Oncology Consultants PA, Houston, TX, USA.
  • Bauer TM; Oregon Health and Science University, Portland, OR, USA.
  • Berry DA; Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, TN, USA.
  • Braiteh F; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Spira A; Berry Consultants, Austin, TX, USA.
  • Meric-Bernstam F; US Oncology Research and Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA.
  • Stein S; Virginia Cancer Specialists, Fairfax, VA, USA.
  • Piha-Paul SA; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Salvado A; Incyte, Wilmington, DE, USA.
Oncotarget ; 9(30): 21383-21395, 2018 Apr 20.
Article in En | MEDLINE | ID: mdl-29765547
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline Language: En Journal: Oncotarget Year: 2018 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline Language: En Journal: Oncotarget Year: 2018 Document type: Article Affiliation country: